Phase I Study to Evaluate the Pharmacokinetics and Safety After Co-administration of L03RD1 and L03RD2 or Administration of L03TD1 in Healthy Volunteers

Clinical trial NCT07533539 · COMPLETED

Trial details

NCT number: NCT07533539
Sponsor: Celltrion
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus (T2DM)

Start date: 2026-05-09
Primary completion: 2026-05-28
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.